OQS
NVRO

Occudo Quantitative Strategies’s NEVRO CORP. NVRO Stock Holding History

Occudo Quantitative Strategies’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-16,087
Closed -$59.8K – 967
2024
Q4 		$59.8K Sell
16,087
-2,165
-12% -$9.99K 0.01% 647
2024
Q3 		$102K Buy
+18,252
New +$128K 0.02% 634
2024
Q2 		– Sell
-17,587
Closed -$254K – 1047
2024
Q1 		$254K Sell
17,587
-20,152
-53% -$333K 0.04% 518
2023
Q4 		$812K Buy
+37,739
New +$673K 0.11% 252
2023
Q3 		– Sell
-9,263
Closed -$235K – 1364
2023
Q2 		$235K Buy
+9,263
New +$267K 0.02% 807

Other funds holding NVRO

BCM
Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.16B AUM 43.32% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $449M AUM 51.52% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Occudo Quantitative Strategies's NVRO Position: Q1 2025 in Review

Occudo Quantitative Strategies sold out of NEVRO CORP. (NVRO) in Q1 2025, closing a stake of 16,087 shares — an estimated $59.8K sold.

Occudo Quantitative Strategies first reported a position in NVRO in Q2 2023 and held it in 5 quarters. The position peaked at $812K in Q4 2023. 126 funds tracked by Wall St. Rank hold NVRO as of Q1 2025.

  • Occudo Quantitative Strategies reported no remaining NEVRO CORP. position as of Q1 2025 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 16,087 NEVRO CORP. shares in Q1 2025, an estimated $59.8K.
  • Occudo Quantitative Strategies first reported a position in NEVRO CORP. in Q2 2023 and held it in 5 quarters.
  • Occudo Quantitative Strategies's NEVRO CORP. position peaked at $812K in Q4 2023.
  • 126 funds tracked by Wall St. Rank held NEVRO CORP. as of Q1 2025.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2025, filed 15 May 2025.